1. 535PLower tumor mutational burden (TMB) and hepatic metastases may predict for lack of response to PD-1 blockade in MSI-H metastatic colorectal cancer (MCRC). (23rd October 2018) Authors: Amanam, I; Chao, J; Lim, D; Rahmanuddin, S; Schrock, A B; Ali, S M; Lau, C; Chevalier, D; Harris, E; Saluja, J; Wang, C; Fakih, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 94 Comparative benefit of olaparib in recurrent BRCAm ovarian, breast, pancreatic and prostate cancer. (13th November 2020) Authors: Peters, P; Manrriquez, E; Amanam, I; Chan, J Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗